The Health Resources and Services Administration should abandon its consideration of a 340B rebate model pilot program ...
A federal court has struck down a 12-year-old Health Resources and Services Administration policy that restricted how certain 340B hospitals could make initial drug purchases, finding that the agency ...
Hospital and pharma groups have sharpened their spears for the rematch on 340B rebates. | The administration's second stab ...
LYNN– At a recent State House briefing hosted by the Massachusetts Health & Hospital Association, healthcare leaders gathered ...
Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that would outweigh the program’s benefits.
In February 2026, the Department of Justice filed amicus briefs supporting pharmaceutical manufacturers, asserting that Rhode ...
AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount ...
AHA urges HRSA to axe 340B model that would cost hospitals over $1 billion annually and increase administrative burdens.
The 340B Drug Pricing Program must be reformed to better patient health and disincentivize institutional profit-seeking ...
The U.S. District Court for the District of Columbia March 31 vacated a Health Resources and Services Administration policy instituted in 2013 that restricted how certain 340B hospitals could make ...
Add Yahoo as a preferred source to see more of our stories on Google. Photo: Shopify Partners / Burst (The Center Square) – Hospitals and clinics in Michigan participating in a federal drug discount ...
Senate Bill 5981, signed into law by Gov. Bob Ferguson on March 25, strengthened the federal 340B Drug Pricing Program, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results